Search result for 'cosmo pharmaceuticals'

Glenmark & Cosmo receive EU marketing authorization for Winlevi (clascoterone cream) to treat acne vulgaris in 15 European countries.

Glenmark Pharmaceuticals and Cosmo Pharmaceuticals have received MHRA approval for Winlevi, a topical treatment for acne vulgaris in the UK. This partnership expands Glenmark's dermatology portfolio.